Guided by Evolution: Biology-Oriented Synthesis of Bioactive Compound Classes

Biology-oriented-synthesis (BIOS), is a chemocentric approach to identifying structurally novel molecules as tools for chemical biology and medicinal chemistry research. The vast chemical space cannot be exhaustively covered by synthetic chemistry. Thus, methods which reveal biologically relevant portions of chemical space are of high value. Guided by structural conservation in the evolution of both proteins and natural products, BIOS classifies bioactive compound classes in a hierarchical manner based on molecular architecture and bioactivity. Biologically relevant scaffolds inspire and guide the synthesis of BIOS libraries, which calls for the development of suitable synthetic methodologies. These compound collections have enriched biological relevance, leading to the discovery of bioactive small molecules. These potent and selective modulators allow the study of complex biological pathways and may serve as starting points for drug discovery programs. Thus, BIOS can also be regarded as a hypothesis-generating tool, guiding the design and preparation of novel, bioactive molecular scaffolds. This review elaborates the principles of BIOS and highlights selected examples of their application, which have in turn created future opportunities for the expansion of BIOS and its combination with fragment-based compound discovery for the identification of biologically relevant small molecules with unprecedented molecular scaffolds.1 Introduction2 Structural Classification of Natural Products3 Implications and Opportunities for Biology-Oriented Synthesis4 Applications of Biology-Oriented Synthesis4.1 Chemical Structure and Bioactivity Guided Approaches4.2 Natural-Product-Derived Fragment-Based Approaches5 Conclusions and Outlook

[1]  Kamal Kumar,et al.  Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery. , 2016, Angewandte Chemie.

[2]  Gianni Chessari,et al.  From fragment to clinical candidate--a historical perspective. , 2009, Drug discovery today.

[3]  R. Hicklin,et al.  Synthesis of complex and diverse compounds through ring distortion of abietic acid. , 2014, Angewandte Chemie.

[4]  D. O'Hagan.  Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids (1998 to 1999) , 2000 .

[5]  H. Waldmann,et al.  An enantioselective inverse-electron-demand imino Diels-Alder reaction. , 2014, Angewandte Chemie.

[6]  Roderick E Hubbard,et al.  How well can fragments explore accessed chemical space? A case study from heat shock protein 90. , 2011, Journal of medicinal chemistry.

[7]  Markus Schürmann,et al.  Branching cascades: a concise synthetic strategy targeting diverse and complex molecular frameworks. , 2011, Angewandte Chemie.

[8]  Michael H Hecht,et al.  Cofactor binding and enzymatic activity in an unevolved superfamily of de novo designed 4‐helix bundle proteins , 2009, Protein science : a publication of the Protein Society.

[9]  Michal Vieth,et al.  Drugs in other drugs: a new look at drugs as fragments. , 2007, Drug discovery today.

[10]  J. Briscoe,et al.  The mechanisms of Hedgehog signalling and its roles in development and disease , 2013, Nature Reviews Molecular Cell Biology.

[11]  Herbert Waldmann,et al.  Discovery of Novel Cinchona-Alkaloid-Inspired Oxazatwistane Autophagy Inhibitors. , 2017, Angewandte Chemie.

[12]  C. Schmidt,et al.  Neuronal growth promoting sesquiterpene-neolignans; syntheses and biological studies. , 2012, Organic & biomolecular chemistry.

[13]  B. Stockwell,et al.  Neurobiological applications of small molecule screening. , 2008, Chemical reviews.

[14]  T. Prisinzano.  Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse. , 2009, Journal of natural products.

[15]  R. Moon,et al.  WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.

[16]  D. O'Hagan.  Pyrrole, pyrrolidine pyridine, piperidine, azepine and tropane alkaloids , 1997 .

[17]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[18]  A. Fürstner.  Gold and platinum catalysis--a convenient tool for generating molecular complexity. , 2009, Chemical Society reviews.

[19]  C. Dobson.  Chemical space and biology , 2004, Nature.

[20]  H. Schöler,et al.  Discovery of neuritogenic compound classes inspired by natural products. , 2013, Angewandte Chemie.

[21]  J. L. Howard,et al.  Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. , 2004, Journal of medicinal chemistry.

[22]  Herbert Waldmann,et al.  Target identification for small bioactive molecules: finding the needle in the haystack. , 2013, Angewandte Chemie.

[23]  R. Kehlenbach,et al.  CRM1-mediated nuclear export: to the pore and beyond. , 2007, Trends in cell biology.

[24]  K. Gademann,et al.  A unified approach for the stereoselective total synthesis of pyridone alkaloids and their neuritogenic activity. , 2011, Angewandte Chemie.

[25]  Gerhard Klebe,et al.  A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes. , 2011, Journal of medicinal chemistry.

[26]  S. Chandrasekhar,et al.  Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity. , 2012, Bioorganic & medicinal chemistry letters.

[27]  H. Schöler,et al.  Highly enantioselective catalytic synthesis of neurite growth-promoting secoyohimbanes. , 2013, Chemistry & biology.

[28]  K. Choi.  Autophagy and cancer , 2012, Experimental & Molecular Medicine.

[29]  G. Grynkiewicz,et al.  Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. , 2008, Pharmacological reports : PR.

[30]  H. Waldmann,et al.  Enantiodivergent Combination of Natural Product Scaffolds Enabled by Catalytic Enantioselective Cycloaddition. , 2016, Angewandte Chemie.

[31]  Su Qiu,et al.  Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. , 2006, Journal of medicinal chemistry.

[32]  M. Butler.  Natural products to drugs: natural product-derived compounds in clinical trials. , 2005, Natural product reports.

[33]  X. Wang,et al.  Nucleophosmin and human cancer. , 2006, Cancer detection and prevention.

[34]  S. Singh,et al.  Chemistry, design, and structure-activity relationship of cocaine antagonists. , 2000, Chemical reviews.

[35]  K. Scheidt,et al.  Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents. , 2007, Angewandte Chemie.

[36]  Stuart L Schreiber,et al.  Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.

[37]  Nature of the intermediates in gold(I)-catalyzed cyclizations of 1,5-enynes. , 2011, Chemistry.

[38]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[39]  L. Hsieh‐Wilson,et al.  Neuroactive chondroitin sulfate glycomimetics. , 2008, Journal of the American Chemical Society.

[40]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[41]  S. Laphookhieo,et al.  Alstoniaphyllines A-C, unusual nitrogenous derivatives from the bark of Alstonia macrophylla. , 2013, Journal of natural products.

[42]  D. Enders,et al.  Asymmetric organocatalytic domino reactions. , 2007, Angewandte Chemie.